Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hewlett Packard Enterprise Co (HPE) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Hewlett Packard Enterprise CoTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Hewlett Packard Enterprise Co vs Regeneron Pharmaceuticals Inc — how do they compare? Hewlett Packard Enterprise Co trades at $55.4 (market cap $72.01B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Hewlett Packard Enterprise Co and Regeneron Pharmaceuticals Inc are close in size by market cap, and Hewlett Packard Enterprise Co pays the higher dividend (1.05%). Which is the better fit depends on your goals.

HPEREGN
Market Cap
$72.01B$82.06B
Sector
TechnologyHealth
52-Week High
$56.14$812.27
52-Week Low
$20.01$555.51
Enterprise Value
$87.96B$76.77B
Dividend Yield
1.05%0.47%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Hewlett Packard Enterprise Co

Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.

Read more on HPE

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN